Chronic lymphocytic leukemia with prostate infiltration mediated by specific clonal membrane-bound IgM

Carol A Bogdan1, Alice A Alexander, Miroslaw K Gorny

  • 1Medical Service, New York Harbor Healthcare System, New York 10010, USA.

Cancer Research
|May 3, 2003
PubMed

Insights

Chronic lymphocytic leukemia (CLL) can rarely infiltrate atypical sites like the prostate. This study reveals that specific surface-bound IgM on CLL cells mediates prostate infiltration by binding to prostate cell antigens.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Chronic lymphocytic leukemia (CLL) typically involves hematopoietic organs.
  • Atypical infiltration of CLL cells into single sites is rare and poorly understood.
  • The specific mechanisms driving unusual CLL cell distribution remain uninvestigated.

Purpose of the Study:

  • To investigate the mechanism behind atypical prostate infiltration in chronic lymphocytic leukemia.
  • To determine if specific molecular interactions mediate CLL cell binding to prostate tissues.

Main Methods:

  • Collected peripheral blood from early-stage CLL patients with prostate infiltration.
  • Performed in vitro binding assays of CLL cells to prostate and other cell lines.
  • Created hybridomas from CLL cells to generate monoclonal antibodies.
  • Utilized flow cytometry and immunohistochemistry to analyze IgM binding.

Main Results:

  • CLL cells from patients with prostate infiltration exhibited strong in vitro binding to prostate cell lines.
  • CLL cells from patients without prostate infiltration did not bind to prostate cells.
  • Monoclonal IgM from hybridomas specifically bound to prostate cells and blocked CLL cell adhesion.
  • Flow cytometry and immunohistochemistry confirmed specific IgM binding to prostate cells.

Conclusions:

  • Specific surface-bound IgM on CLL cells, targeting prostate-specific antigens, mediates atypical prostate infiltration.
  • This mechanism may also explain CLL infiltration into other atypical organs.
  • Understanding this interaction opens avenues for targeted therapies in CLL.

Related Concept Videos